News

In surgery, material selection is crucial to ensuring patient safety and surgical success. Among these materials, surgical sutures and mesh components are crucial for wound closure and tissue support. One of the earliest synthetic materials used in surgical mesh was polyester, invented in 1939. While affordable and readily available, polyester mesh has several limitations, prompting the development of more

advanced alternatives, such as monofilament polypropylene mesh. Polyester mesh is still used by some surgeons due to its cost-effectiveness, but there are challenges with biocompatibility. The fiber structure of polyester yarn can trigger severe inflammatory reactions and foreign body reactions, making it less suitable for long-term implantation. In contrast, monofilament polypropylene mesh offers excellent anti-infection properties and a reduced risk of complications, making it the preferred choice for many surgical procedures. As the medical field continues to advance, the need for materials that can improve patient outcomes remains a top priority.

At WEGO, we understand the importance of innovative medical products, including surgical sutures and mesh components. With over 80 subsidiaries and over 30,000 employees, we are committed to advancing healthcare by developing high-quality medical solutions. Our broad product portfolio spans seven industry categories, including medical products, orthopedics, and cardiac consumables, ensuring we can meet the diverse needs of healthcare providers and patients.

Looking ahead, WEGO will continue its commitment to research and development in surgical materials. We specialize in integrating advanced technologies with biocompatible materials, aiming to provide surgeons with the tools they need to enhance surgical outcomes and improve patient care. The evolution of surgical suture and mesh components demonstrates our ongoing commitment to medical excellence, and WEGO is proud to be at the forefront of this important industry.